As of 2025-05-16, the Relative Valuation of ZIOPHARM Oncology Inc (ZIOP) is (5.94) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.87 USD, the upside of ZIOPHARM Oncology Inc based on Relative Valuation is -785.7%.
The range of the Relative Valuation is (3.64) - (7.57) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 8.4x - 18.2x | 14.0x |
| Forward P/E multiples | 8.8x - 20.4x | 14.6x |
| Fair Price | (3.64) - (7.57) | (5.94) |
| Upside | -520.0% - -974.6% | -785.7% |
| Date | P/E |